Immunotherapy Plus Chemotherapy Versus Chemotherapy Alone as First-Line Treatment for Advanced Urothelial Cancer: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunotherapy Plus Chemotherapy Versus Chemotherapy Alone as First-Line Treatment for Advanced Urothelial Cancer: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials

Published:2024-10 Issue:5 Volume:22 Page:102154
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Mamede Isadora^ORCID,Escalante-Romero Lorena^ORCID,Celso Davi S. Gonçalves^ORCID,Reis Pedro C. Abrahao^ORCID,Dacoregio Maria Inez,Alves Ana Caroline,Stecca Carlos

Publisher

Elsevier BV

Reference32 articles.

1. New therapeutic challenges in advanced bladder cancer;Bellmunt;Semin Oncol,2012

2. Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma;Galsky;Ann Oncol,2012

3. Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆;Powles;Ann Oncol,2022

4. European Association of Urology. European Association of Urology Guidelines on muscle-invasive and metastatic bladder cancer. Published online 2023.

5. Avelumab maintenance therapy for advanced or metastatic urothelial carcinoma;Powles;N Engl J Med,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP